Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Tiotiu (London, United Kingdom), N. Kermani (London, United Kingdom), P. Agapow (London, United Kingdom), M. Saqi (London, United Kingdom), Y. Guo (London, United Kingdom), R. Djukanovic (Southampton, United Kingdom), K. Chung (London, United Kingdom), I. Adcock (London, United Kingdom). Differential macrophage activation in asthmatic sputum using U-BIOPRED transcriptomics. 2337

Member's Comments

No comment yet.

Related content which might interest you: Cytokine receptors expression in induced sputum in asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 159s Year: 2001 Bacterial exacerbation of COPD: assessment of neutrophil activation in induced sputum Source: Annual Congress 2004 - Role of infection in COPD Year: 2004 Induced sputum cell count and Th1/Th2 cytokine profile in asthmatic and healthy children Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood Year: 2010 Differential mast cell activation by transcriptomic signature analysis in the U-BIOPRED severe asthma cohort Source: Virtual Congress 2020 – Novel methods, diagnostics and biomarkers of chronic lung diseases Year: 2020 Sputum supernatant profiling reveals inflammasome-associated signatures in severe asthmatics in U-BIOPRED Source: International Congress 2015 – Advances in the future treatment of severe asthma Year: 2015 Cysteinyl-leukotrienes contribute to sputum eosinophil chemotactic activity in asthma Source: Eur Respir J 2005; 26: Suppl. 49, 734s Year: 2005 Induced sputum and blood T lymphocyte activation during exacerbations of severe asthmatics: the ISEA study Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma Year: 2006 Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis Source: Eur Respir J 2003; 21: 582-588 Year: 2003 Mechanisms of noneosinophilic asthma Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Neutrophil activation in asthma Source: Eur Respir J 2003; 22: Suppl. 45, 400s Year: 2003 Role of sputum eosinophil levels in the assessment of asthma treatment Source: Eur Respir J 2004; 24: Suppl. 48, 579s Year: 2004 Correlation of bronchoalveolar lavage eosinophil and mast cell activation with bronchial hyperresponsiveness in children with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 379s Year: 2002 Induced sputum cytokines and chemokines and mechanistic pathways in adult asthma phenotypes Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 Contribution of eotaxin (CCL11) to eosinophil chemotactic activity of asthmatic sputum Source: Eur Respir J 2002; 20: Suppl. 38, 208s Year: 2002 Assessment of airway neutrophil activation in adult non-eosinophilic asthma Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011 LSC - 2019 - Sputum protein profiling identifies a key role for neutrophil extracellular traps in exacerbations of bronchiectasis and treatment response Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Biological markers of inflammation in asthma in children - eosinophils in sputum and ECP in peripheral blood Source: Eur Respir J 2005; 26: Suppl. 49, 625s Year: 2005 Inflammatory cell profiles in asthmatic infants assessed by induced sputum Source: Annual Congress 2009 - Airway inflammation and asthma control Year: 2009 Monitoring of sputum eosinophils in long-term treatment of bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 111s Year: 2002 Chemokines receptors expression in induced sputum in COPD and asthma Source: Annual Congress 2003 - Activation, migration and death of immune cells Year: 2003